SKI Market

Indian Indices

Sensex

76,863.71 -1,342.27
( -1.72%)

Global Indices

Nasdaq

47,717.90 -43.91
(-0.09%)

Dow Jones

6,802.01 -14.98
(-0.22%)

Hang Seng

55,018.23 769.84
(1.42%)

Nikkei 225

10,315.38 -96.86
(-0.93%)

Forex

USD-INR

92.14 0.30
(0.32%)

EUR-INR

106.58 -0.02
(-0.02%)

GBP-INR

123.09 0.04
(0.04%)

JPY-INR

0.58 0.00
(0.05%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

JFL Life Sciences Ltd

Industry : Pharmaceuticals - Indian - Formulations

BSE Code

ISIN Demat

Book Value()

535469

INE0LA901015

11.3920003

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

JFLLIFE

15.07

72.59

EPS(TTM)

Face Value()

Div & Yield %

0.73

Back

birla corporation ltd

National Standard (India) Ltd - Board Meeting Intimation for Considering And Approval Of Un-Audited Financial Results Of The Company For The Quarter And Half Year Ended September 30 2025

Oct 10,2025

National Standard (India) Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 16/10/2025 inter alia to consider and approve Un-audited Financial Results of the Company for the quarter and half year ended September 30 2025

76,863.71 -1,342.27 ( -1.72%)

47,717.90 -43.91 (-0.09%)

6,802.01 -14.98 (-0.22%)

55,018.23 769.84 (1.42%)

10,315.38 -96.86 (-0.93%)

92.14 0.30 (0.32%)

106.58 -0.02 (-0.02%)

123.09 0.04 (0.04%)

0.58 0.00 (0.05%)